Wuxi Buys Instem’s Remote Study Monitoring Tool

By Zachary Brennan

- Last updated on GMT

Related tags: Pre-clinical development, Jiangsu

Wuxi Buys Remote  Monitoring Tech
Wuxi Buys Remote Monitoring Tech
China’s top CRO Wuxi Apptec has purchased a remote clinical trial monitoring tool that will allow its toxicology clients log onto a secure Web site to view data from on-going studies.

The purchase of the Provantis portal remote study monitoring tool comes a little more than a year after Instem launched the technology, which is designed to allow sponsors to view data from their on-going studies on-demand on a secure site that can be accessed from any internet browser.

The speed and quality of communications made possible by the Provantis portal supports our commitment to better serve our customers globally through high-quality services​,” Neil Donaldson, VP of Asian and European Operations at Instem, said.

Instem established a full-service office in Shanghai, recruited local staff and has localized the Provantis product suite into Mandarin Chinese.

In addition, Instem will provide supporting international organizations and domestic laboratories using on-site systems a delivery model from a professionally managed data center based in Shanghai.

Wuxi previously partnered with Instem in 2009 on a preclinical research monitoring tool, which it used to automate study processes at its drug toxicology testing facility in Suzhou, China.

New China JV chief

News of the Chinese CRO’s acquisition of Provantis coincides with the news that ex-Theorem CEO James Pursey has been hired as president and general manager of the joint venture organisation Wuxi and PRA set up in Shanghai earlier this year.

WuXi’s mission is to create a broad, integrated platform of R&D services that will allow anyone and any company to develop new medicines efficiently and cost effectively​,” Stephen Mason, VP of operations for preclinical services at Wuxi said. 

It is unclear whether the JV – named WuxiPRA - will be offering the Provantis data portal system to the pharmaceutical companies with which it works.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars